Haemophilus influenzae

Haemophilus influenzae is a bacterial species and Gram-negative bacillus that occurs as an exclusively human pathogen and commensal ^[1]. The source material notes six capsular serotypes, a through f, and identifies type b (Hib) as a major cause of childhood infectious disease ^[1]. In the available sources, the organism is discussed in relation to acute infectious meningitis burden and to clinical syndromes attributable to Hib and non-typeable strains ^[1][2].

Source-backed clinical detail is uneven, but the available material links Hib in infants to a spectrum ranging from mild non-specific febrile illness or occult bacteraemia to sepsis with meningitis, epiglottitis, pneumonia, septic arthritis, or cellulitis ^[1]. Non-typeable H. influenzae are described as nasopharyngeal commensals that cause otitis media and conjunctivitis in children, and as causes of exacerbations of chronic bronchitis, sinusitis, and pneumonia in adults ^[1]. For bacterial meningitis more broadly, the outcome is related to inflammation in the subarachnoid space, and adjunctive corticosteroid therapy has been studied for mortality, hearing loss, and neurological sequelae ^[3]. The present sources do not provide organism-specific complication frequencies or timing.

The available evidence places H. influenzae within the global burden of acute infectious meningitis, where aetiologic estimates were modeled across 204 countries and territories using multiple mortality, surveillance, and literature sources ^[2]. In the broader bacterial meningitis literature, studies spanning 108 countries over 1935–2019 reported 157,656 episodes, illustrating that the pathogen context is globally distributed rather than regionally confined ^[4]. The organism is described as an exclusively human pathogen, with carriage that may be followed by disease in susceptible individuals, and the main source of transmission is other children through close bodily contact ^[1]. Source-backed detail on seasonality, outbreak pattern, or specific geographic hotspots is not yet available.

Transmission occurs by close bodily contact, and the main source is stated to be other children ^[1]. The organism is also described as a commensal, and carriage may be followed by disease in susceptible individuals ^[1]. The available sources do not provide more granular detail on persistence, respiratory droplets, fomites, or duration of carriage, so those elements are not included here.

The sources most clearly identify infants and children as the principal affected groups for Hib-associated disease, with children also noted as the main source in transmission ^[1]. Adults are mentioned in relation to non-typeable H. influenzae causing exacerbations of chronic bronchitis, sinusitis, and pneumonia ^[1]. Beyond these age-linked observations, source-backed detail on immunocompromise, comorbidity, or other specific high-risk groups is not yet available.

The sources support prevention primarily in the public-health sense of burden reduction and control of invasive disease, noting that meningitis is largely preventable and that WHO has set goals to reduce meningitis cases by 2030 ^[2]. The literature also explicitly raises vaccination as one of the interventions whose impact on pathogen distribution and outcome has shaped the bacterial meningitis landscape, although the magnitude of effect for H. influenzae is not quantified in the provided material ^[4]. Because the evidence boundary is limited, specific vaccine schedules, chemoprophylaxis, or exposure-control protocols are not stated here.

For surveillance, H. influenzae should be interpreted as part of aetiologic tracking for acute infectious meningitis and other invasive bacterial syndromes rather than as a single clinical presentation ^[2][4]. The available sources support monitoring by age, pathogen type, and burden trend, but they do not supply organism-specific thresholds, alert definitions, or seasonality markers ^[2]. In a monitoring context, the key signal is the burden of invasive disease attributable to Hib and related H. influenzae categories, with carriage and non-invasive syndromes also relevant to interpretation ^[1][2].

1. 1 Haemophilus influenzae. Oxford Textbook of Medicine. 2020. doi: 10.1093/med/9780198746690.003.0117. DOI: https://doi.org/10.1093/med/9780198746690.003.0117
2. 2 GBD 2019 Meningitis Antimicrobial Resistance Collaborators et al. Global, regional, and national burden of meningitis and its aetiologies, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2023 Aug. PMID: 37479374. doi: 10.1016/S1474-4422(23)00195-3. PubMed: https://pubmed.ncbi.nlm.nih.gov/37479374/
3. 3 van Ettekoven CN et al. Global Case Fatality of Bacterial Meningitis During an 80-Year Period: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2024 Aug 1. PMID: 39093565. doi: 10.1001/jamanetworkopen.2024.24802. PubMed: https://pubmed.ncbi.nlm.nih.gov/39093565/
4. 4 Brouwer MC et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12. PMID: 26362566. doi: 10.1002/14651858.CD004405.pub5. PubMed: https://pubmed.ncbi.nlm.nih.gov/26362566/
5. 5 Haemophilus influenzae. Revue des Maladies Respiratoires Actualités. 2020. doi: 10.1016/j.rmra.2020.08.005. DOI: https://doi.org/10.1016/j.rmra.2020.08.005
6. 6 Haemophilus influenzae. Revista chilena de infectología. 2013. doi: 10.4067/s0716-10182013000600015. DOI: https://doi.org/10.4067/s0716-10182013000600015

ICD-10

ICD-11

Total cases

41K

Peak month

2023-01

Coverage

8 reporting countries · 2000-01-01 → 2026-06-20